To bring cutting-edge diagnostic platforms to clinical use, Roche introduced the AXELIOS sequencing-by-expansion (SBX) ...

Eight months after more than doubling down on its construction of a $2 billion drug manufacturing facility in Holly Springs, North Carolina, Roche is making a similar move on the other side of the ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.

INDIANAPOLIS, July 22, 2026 /PRNewswire/ -- (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing shortages and increasingly complex workflows, Roche will showcase integrated ...

Roche announced that it introduces the cobas HDV test for use on the cobas 5800/6800/8800 systems, a diagnostic tool for the detection and quantification of Hepatitis D Virus (HDV) RNA, in countries ...

Disponible sur les systèmes entièrement automatisés Cobas 5800/6800/8800, ce nouveau test permet aux professionnels de santé de diagnostiquer de manière fiable le HDV et de surveiller la réponse au ...

Roche Holding AG expects to launch the breast cancer pill that may become one of its biggest sellers by the end of the year, sparking optimism about its prospects. The medicine, called giredestrant, ...

It’s the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster. Pharmaceutical giant Roche said today it is launching a new large-scale “AI factory ...

Pharmaceutical and diagnostics giant Roche announced it will fund a $550 million diagnostic center in Indianapolis by 2030. The manufacturing hub will produce Roche's continuous glucose monitoring ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in its ...

Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. The company’s cobas ...